Mouse models of endocrine tumours

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 3, 2010, Pages 451-460

  Jones, Georgette N ^a   Manchanda, Parmeet K ^a   Pringle, Daphne R ^a   Zhang, Mei ^a   Kirschner, Lawrence S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

endocrine neoplasia syndromes; knockout mice; oncogenes; transgenic mice; tumour suppressor genes

Indexed keywords

METHIONINE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADRENAL TUMOR; CARCINOGENESIS; CARNEY COMPLEX; COWDEN SYNDROME; DISEASE MODEL; ENDOCRINE TUMOR; GENETIC MODEL; HUMAN; HYPOPHYSIS TUMOR; KNOCKOUT MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; REVIEW; SIPPLE SYNDROME; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; ENDOCRINE GLAND NEOPLASMS; HUMANS; MICE;

EID: 77956597311     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.01.004     Document Type: Review

References (73)

1. P. Wermer Genetic aspects of adenomatosis of endocrine glands The American Journal of Medicine 16 1954 363 371
2. A.A. Pannett, and R.V. Thakker Multiple endocrine neoplasia type 1 Endocrine-Related Cancer 6 4 1999 449 473
3. S.K. Agarwal, S.C. Guru, and C. Heppner Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription Cell 96 1 1999 143 152
4. S.I. Hirai, R.P. Ryseck, and F. Mechta Characterization of junD: a new member of the jun proto-oncogene family The EMBO Journal 8 5 1989 1433 1439
5. C.M. Pfarr, F. Mechta, and G. Spyrou Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras Cell 76 4 1994 747 760
6. K. Ryder, A. Lanahan, and E. Perez-Albuerne jun-D: a third member of the jun gene family Proceedings of the National Academy of Sciences of the United States of America 86 5 1989 1500 1503
7. D. Trump, B. Farren, and C. Wooding Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM 89 9 1996 653 669
8. S.C. Chandrasekharappa, S.C. Guru, and P. Manickam Positional cloning of the gene for multiple endocrine neoplasia-type 1 Science 276 5311 1997 404 407
9. P. Bertolino, I. Radovanovic, and H. Casse Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs Mechanisms of Development 120 5 2003 549 560
10. K.A. Loffler, C.A. Biondi, and M. Gartside Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1 International Journal of Cancer 120 2 2007 259 267
11. J.S. Crabtree, P.C. Scacheri, and J.M. Ward Of mice and MEN1: Insulinomas in a conditional mouse knockout Molecular and Cellular Biology 23 17 2003 6075 6085
12. S.K. Libutti, J.S. Crabtree, and D. Lorang Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism Cancer Research 63 22 2003 8022 8028
13. F.M. Michiels, S. Chappuis, and B. Caillou Development of medullary thyroid carcinoma in transgenic mice expressing the RET proto-oncogene altered by a multiple endocrine neoplasia type 2A mutation Proceedings of the National Academy of Sciences of the United States of America 94 7 1997 3330 3335
14. C. Gestblom, D.A. Sweetser, and B. Doggett Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice The American Journal of Pathology 155 6 1999 2167 2179
15. N. Schulz, F. Propst, and M.P. Rosenberg Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome Cancer Research 52 2 1992 450 455
16. J.A. Carney, H. Gordon, and P.C. Carpenter The complex of myxomas, spotty pigmentation, and endocrine overactivity Medicine (Baltimore) 64 4 1985 270 283
17. L.S. Kirschner, J.A. Carney, and S.D. Pack Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex Nature Genetics 26 1 2000 89 92
18. L.S. Kirschner, F. Sandrini, and J. Monbo Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex Human Molecular Genetics 9 20 2000 3037 3046
19. L.S. Kirschner, D.F. Kusewitt, and L. Matyakhina A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues Cancer Research 65 11 2005 4506 4514
20. C.A. Stratakis, N.A. Courcoutsakis, and A. Abati Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex) The Journal of Clinical Endocrinology and Metabolism 82 7 1997 2037 2043
21. Z. Yin, G.N. Jones, and W.H. Towns 2nd heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis Circulation 117 2008 1414 1422
22. Z. Yin, L. Williams-Simons, and L. Rawahneh Development of a pituitary-specific cre line targeted to the Pit-1 lineage Genesis 46 1 2008 37 42
23. Z. Yin, L. Williams-Simons, and A.F. Parlow Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis Molecular Endocrinology 22 2 2008 380 387
24. G.N. Jones, C. Tep, and W.H. Towns 2nd Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production Neoplasia 10 11 2008 1213 1221
25. A.O. Stemmer-Rachamimov, D.N. Louis, and G.P. Nielsen Comparative pathology of nerve sheath tumors in mouse models and humans Cancer Research 64 10 2004 3718 3724
26. D. Liaw, D.J. Marsh, and J. Li Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Nature Genetics 16 1 1997 64 67
27. K. Podsypanina, L.H. Ellenson, and A. Nemes Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proceedings of the National Academy of Sciences of the United States of America 96 4 1999 1563 1568
28. V. Stambolic, M.S. Tsao, and D. Macpherson High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice Cancer Research 60 13 2000 3605 3611
29. A. Di Cristofano, B. Pesce, and C. Cordon-Cardo Pten is essential for embryonic development and tumour suppression Nature Genetics 19 4 1998 348 355
30. D. Freeman, R. Lesche, and N. Kertesz Genetic background controls tumor development in PTEN-deficient mice Cancer Research 66 13 2006 6492 6496
31. M.L. Chen, P.Z. Xu, and X.D. Peng The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice Genes & Development 20 12 2006 1569 1574
32. N. Yeager, A. Klein-Szanto, and S. Kimura Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis Cancer Research 67 3 2007 959 966
33. C.J. Guigon, L. Zhao, and M.C. Willingham PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer Oncogene 28 4 2009 509 517
34. M. Grieco, M. Santoro, and M.T. Berlingieri PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas Cell 60 4 1990 557 563
35. I. Bongarzone, M.G. Butti, and S. Coronelli Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas Cancer Research 54 11 1994 2979 2985
36. M. Santoro, N.A. Dathan, and M.T. Berlingieri Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma Oncogene 9 2 1994 509 516
37. G. Sozzi, M.A. Pierotti, and M. Miozzo Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC Oncogene 6 2 1991 339 342
38. F. Minoletti, M.G. Butti, and S. Coronelli The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2 Genes Chromosomes Cancer 11 1 1994 51 57
39. M. Santoro, G. Chiappetta, and A. Cerrato Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice Oncogene 12 8 1996 1821 1826
40. S.M. Jhiang, J.E. Sagartz, and Q. Tong Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas Endocrinology 137 1 1996 375 378 (Pubitemid 26005013)
41. D.J. Powell Jr., J. Russell, and K. Nibu The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids Cancer Research 58 23 1998 5523 5528
42. T.L. Buckwalter, A. Venkateswaran, and M. Lavender The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation Oncogene 21 53 2002 8166 8172
43. K.M. La Perle, S.M. Jhiang, and C.C. Capen Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas The American Journal of Pathology 157 2 2000 671 677
44. M. Xing BRAF mutation in thyroid cancer Endocrine-Related Cancer 12 2 2005 245 262
45. J.A. Knauf, X. Ma, and E.P. Smith Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation Cancer Research 65 10 2005 4238 4245
46. M.R. Haymart, D.J. Repplinger, and G.E. Leverson Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage The Journal of Clinical Endocrinology and Metabolism 93 3 2008 809 814
47. F.M. Michiels, B. Caillou, and M. Talbot Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice Proceedings of the National Academy of Sciences of the United States of America 91 22 1994 10488 10492
48. M.A. Zeiger, M. Saji, and Y. Gusev Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice Endocrinology 138 8 1997 3133 3140
49. L. Pei, and S. Melmed Isolation and characterization of a pituitary tumor-transforming gene (PTTG) Molecular Endocrinology 11 4 1997 433 441
50. X. Zhang, G.A. Horwitz, and A.P. Heaney Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas The Journal of Clinical Endocrinology and Metabolism 84 2 1999 761 767
51. R.A. Abbud, I. Takumi, and E.M. Barker Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice Molecular Endocrinology 19 5 2005 1383 1391
52. I. Donangelo, S. Gutman, and E. Horvath PTTG over-expression facilitates pituitary tumor development Endocrinology 2006
53. O. Vierimaa, M. Georgitsi, and R. Lehtonen Pituitary adenoma predisposition caused by germline mutations in the AIP gene Science 312 5777 2006 1228 1230
54. B.C. Lin, R. Sullivan, and Y. Lee Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality The Journal of Biological Chemistry 282 49 2007 35924 35932
55. C.A. Koch, K. Pacak, and G.P. Chrousos The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors The Journal of Clinical Endocrinology and Metabolism 87 12 2002 5367 5384
56. B.D. Looyenga, and G.D. Hammer Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex Molecular Endocrinology 20 11 2006 2848 2863
57. A. Horvath, S. Boikos, and C. Giatzakis A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia Nature Genetics 38 7 2006 794 800
58. A. Horvath, V. Mericq, and C.A. Stratakis Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia The New England Journal of Medicine 358 7 2008 750 752
59. M. Tadjine, A. Lampron, and L. Ouadi Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas Clinical Endocrinology 68 2 2008 264 270
60. T. Jacks, A. Fazeli, and E.M. Schmitt Effects of an Rb mutation in the mouse Nature 359 6393 1992 295 300
61. L. Yamasaki, R. Bronson, and B.O. Williams Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice Nature Genetics 18 4 1998 360 364
62. E.Y. Lee, H. Cam, and U. Ziebold E2F4 loss suppresses tumorigenesis in Rb mutant mice Cancer Cell 2 6 2002 463 472
63. K. Nakayama, N. Ishida, and M. Shirane Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 5 1996 707 720
64. H. Kiyokawa, R.D. Kineman, and K.O. Manova-Todorova Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) Cell 85 5 1996 721 732
65. M.L. Fero, M. Rivkin, and M. Tasch A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice Cell 85 5 1996 733 744
66. W.M. Chien, K. Garrison, and E. Caufield Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis Cell Cycle 6 6 2007 750 757
67. N.S. Pellegata, L. Quintanilla-Martinez, and H. Siggelkow Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans Proceedings of the National Academy of Sciences of the United States of America 103 42 2006 15558 15563
68. M. Georgitsi, A. Raitila, and A. Karhu Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia The Journal of Clinical Endocrinology and Metabolism 92 8 2007 3321 3325
69. D.S. Franklin, V.L. Godfrey, and H. Lee CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis Genes & Development 12 18 1998 2899 2911
70. M.S. Park, J. Rosai, and H.T. Nguyen p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice Proceedings of the National Academy of Sciences of the United States of America 96 11 1999 6382 6387
71. K.L. Guan, C.W. Jenkins, and Y. Li Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function Genes & Development 8 24 1994 2939 2952
72. S.W. Leung, E.H. Wloga, and A.F. Castro A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis Oncogene 23 19 2004 3296 3307
73. J.S. Crabtree, P.C. Scacheri, and J.M. Ward A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors Proceedings of the National Academy of Sciences of the United States of America 98 2001 1118 1123